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Abstract
Vibrio coralliilyticus is an important coral pathogen demonstrated to cause
disease outbreaks worldwide. This study investigated the feasibility of applying
bacteriophage therapy to treat the coral pathogen V. coralliilyticus. A specific
bacteriophage for V. coralliilyticus strain P1 (LMG23696), referred to here as
bacteriophage YC, was isolated from the seawater above corals at Nelly Bay,
Magnetic Island, central Great Barrier Reef (GBR), the same location where the
bacterium was first isolated. Bacteriophage YC was shown to be a lytic phage
belonging to the Myoviridae family, with a rapid replication rate, high burst
size, and high affinity to its host. By infecting its host bacterium, bacteriophage
YC was able to prevent bacterial-induced photosystem inhibition in pure
cultures of Symbiodinium, the photosymbiont partner of coral and a target for
virulence factors produced by the bacterial pathogen. Phage therapy experi-
ments using coral juveniles in microtiter plates as a model system revealed that
bacteriophage YC was able to prevent V. coralliilyticus-induced photoinactivation
and tissue lysis. These results demonstrate that bacteriophage YC has the potential
to treat coral disease outbreaks caused by the bacterial pathogen V. coralliilyticus,
making it a good candidate for phage therapy treatment of coral disease.
Introduction
Coral reefs are highly diverse and dynamic ecosystems,
often compared with tropical rainforests in their
biological complexity (Reaka-Kudla 1997). They are also
one of the most productive ecosystems on earth, generat-
ing structural habitat and nutrition for a wide variety of
species, including vertebrates, invertebrates, algae, and
microorganisms (Hoegh-Guldberg 1999). However,
assessments over recent decades have documented dra-
matic deterioration in coral reef health with 1–2% annual
declines of coral cover over broad areas of the Indo-Paci-
fic and greater than 50% cover coral loss of in some
regions (Bruno and Selig 2007). Factors contributing to
these declines include poor water quality associated with
increased sedimentation and nutrients from disturbed
coastlines, over exploitation of key marine species,
destructive fishing, and pollution (Hughes et al. 2003).
Moreover, these anthropogenic impacts, combined with
rising seawater temperatures linked to climate change and
increased greenhouse gases, have been correlated with the
spread of coral diseases (Knowlton 2001; Bourne et al.
2009). The ecological consequences of widespread disease
outbreaks include lowered coral reproduction and growth
rates, altered community structures, and decreased abun-
dance of other reef-associated organisms (Loya et al.
2001).
Although more than 20 coral diseases have been
described, causative agents have been isolated for only a
few diseases (Rosenberg et al. 2007; Bourne et al. 2009).
Bacteria, viruses, protozoa, and fungi have all been shown
to cause lesions on corals, often leaving the skeleton free
of any live tissue. Vibrio coralliilyticus is an emerging coral
pathogen that has been associated with coral disease from
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geographically distinct global regions. First isolated from
diseased and bleaching corals off the coast of Zanzibar
(Ben-Haim et al. 2003a,b), this species has also been
implicated in white syndrome disease outbreaks in the
Indo-Pacific (Sussman et al. 2008). Recent studies have
demonstrated the ability of V. coralliilyticus strains to also
cause disease in soft coral species, oyster larvae, and
bivalves larvae (Hada et al. 1984; Austin et al. 2005; Bally
and Garrabou 2007) in the other parts of the world. In
hard corals, infection by V. coralliilyticus results in paling
of coral tissues due to loss of Symbiodinium cells from
the coenosarc tissue (the live tissue between polyps) and
subsequent tissue loss leaving behind bare, white skeleton
(Sussman et al. 2008, 2009). Vibrio coralliilyticus was
found to have high proteolytic activity, producing a Zn-
metalloprotease protein that plays an important role in
the cleavage of connective tissue and other cellular pertur-
bations. Addition of V. coralliilyticus supernatants to coral
juveniles causes not only inhibition of photosynthetic
activity, as with the in vitro Symbiodinium cells, but also
loss of Symbiodinium cells from the coral juveniles and
rapid onset of tissue lesions followed by complete mortal-
ity of the juvenile colony (Sussman et al. 2009). Vibrio
coralliilyticus is an important model coral bacterial
pathogen, with information accumulating on its virulence
capacity, genome structure (De Santos et al. 2011), and
protein expression potential (Kimes et al. 2012).
The worldwide decline of coral reefs necessitates the
development of tools and strategies for the control and
treatment of coral diseases. Coral diseases caused by bac-
terial infection cannot be treated with antibiotics because
of the general effect of antibiotics on bacteria and the
potential dangers of selection for antibiotic-resistant
strains (Parisien et al. 2007). Corals also do not have an
adaptive immune system (Nair et al. 2005) and therefore
cannot be immunized to prevent infection. Phage therapy
represents a promising alternative strategy for treatment
of disease outbreaks (Housby and Mann 2009). Recent
studies have reported successful closed system phage ther-
apy trials on Pocillopora damicornis coral undergoing
bleaching and tissue lysis caused by V. coralliilyticus strain
YB1 and white-plague-like disease of Favia favus caused
by Thalassomonas loyaeana (Efrony et al. 2007, 2009).
While these studies demonstrate the potential for phage
therapy in treating coral diseases in the Red Sea, similar
investigations have not been conducted in other regions
of the world. The study presented here investigates the
potential of phage therapy for treatment of coral disease
on Australia’s Great Barrier Reef. A phage specifically
infecting V. coralliilyticus strain P1 was isolated from the
waters of Nelly Bay, Magnetic Island, and tested in model
systems, including cultured coral endosymbionts and
coral juveniles.
Materials and Methods
Bacterial strain, growth media, and culture
conditions
The bacterial strain used in this study was V. coralliilyti-
cus P1 (LMG23696), previously isolated from diseased
Montipora aequituberculata coral colonies at Magnetic
Island off the coast from Townsville, within the central
section of the Great Barrier Reef Marine Park (Sussman
et al. 2008). Strain P1 was maintained on MB agar
plates containing: 1.8% Difco Marine Broth (Difco,
Detroit, MI), 0.9% NaCl, and 1.8% Difco Bacto agar.
This strain was grown routinely in liquid marine broth
tryptone (MBT) medium containing 1.8% Difco Marine
Broth, 0.9% NaCl, and 0.45% Difco Bacto Tryptone.
Liquid cultures of strain P1 were prepared from single
bacterial colonies inoculated into 50-mL Falcon tubes
containing 10 mL of MBT and then incubated at
28°C in a shaking incubator at 190 revolutions per min-
ute (rpm) for 24 h.
Bacteriophage isolation and preparation of
high-titer phage stocks
Three liters of seawater were collected from Nelly Bay,
Magnetic Island, the same location where strain P1 was
originally isolated. The seawater was treated with 0.5%
chloroform and filtered successively through 0.8-lm
and 0.22-lm membrane filters (Millipore, Bedford,
MA). A series of enrichments was performed, first by
adding 1 mL of bacteria (109 cells) and 10 mL of MBT
into 100 mL of the filtrate and incubating for 24 h in
a shaking incubator at 28°C and 210 rpm. This first
enrichment was centrifuged at 5250g and then filtered
through 0.22-lm syringe filters (Millex, Millipore). The
second enrichment was performed by adding 1 mL of
the first enrichment to 40 mL of MBT and 1 mL of
bacteria (109 cells) and incubating for 24 h with
shaking at 210 rpm. A 2-mL aliquot of the resulting
culture was centrifuged at 5250g and filtered through a
0.22-lm syringe filter. Both enrichments were plated
according to the soft agar overlay technique described
by Adams (1959) using strain P1 as a bacterial lawn
for plaque formation. Several rounds of plaque purifica-
tions were performed to ensure a pure phage stock.
High-titer phage lysates were prepared by infecting
strain P1 (approximately 109 cells) with isolated
plaques. After 5 h, the culture became clear, and
following centrifugation at 5250g and 0.22-lm syringe
filtration, the phage lysate was free of bacterial contam-
inants. The resulting purified phage was termed bacte-
riophage YC.
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Electron microscopy
Morphology-based classification of bacteriophage YC was
determined using transmission electron microscopy
(TEM). The filtered high-titer phage lysate (109 pfu/mL)
was negatively stained with 1% uranyl acetate and exam-
ined by JOEL 840A electron microscope at 80 kV as
described by Efrony et al. (2007).
Phage nucleic acid purification
Bacteriophage YC lysate (109 pfu/mL) was treated with
DNase I and RNase A at 37°C for 15 min to remove any
contaminating free nucleic acids. The phage was then
concentrated and precipitated using 20% polyethylene
glycol 8000 (PEG 8000) containing 2 mol/L NaCl, EDTA
(to a final concentration of 20 mmol/L), and 0.5% SDS
followed by incubation at 68°C for 5 min. The resulting
phage nucleic acid was purified using a phenol/chloro-
form, chloroform, and isopropanol extraction and precip-
itated with 70% cold ethanol (Sambrook et al. 1989).
Genome size of bacteriophage YC was determined with
1% agarose gel electrophoresis, using two DNA ladders as
markers: Gene Ruler 1-kb DNA ladder and Gene Ruler
10-kb DNA ladder (Fermentas Inc., Hanover, MD).
One-step growth curve
One-step burst size experiments were performed in MBT
medium by adding 107 bacteria and 105 bacteriophage
(multiplicity of infection [M.O.I.] = 0.01). Exponentially
growing cultures of strain P1 were infected with bacterio-
phage YC and incubated for 5 min at 30°C to allow the
phage to adsorb onto the bacteria. The cultures were than
centrifuged at 9000 rpm and the pellet resuspended in
1-mL MBT to eliminate free phage. Samples were plated
periodically using the soft agar overlay technique, and
plaques were counted after overnight incubation at 30°C.
Bacteriophage adsorption kinetics
experiments
Strain P1 was grown overnight to a culture density of
109 cells/mL, the bacteria were pelleted by centrifugation
at 5250g, and the pellet was washed twice with filtered arti-
ficial seawater (FASW). An adsorption kinetics experiment
was then performed by adding 104 phage/mL to bacteria
diluted in FASW to three different bacterial concentra-
tions: 105 P1/mL, 104 P1/mL, and 103 P1/mL. The bacteria
and phage mixture were introduced into 20 mL ASW to
resemble the natural seawater environment. In flasks con-
taining 105 P1/mL and 104 phage/mL, samples were taken
every 10 min for 60 min; in flasks containing 104 P1/mL
and 104 phage/mL, samples were taken every 20 min for
120 min, and in flasks containing 103 P1/mL and 104
phage/mL, samples were taken every 30 min for 180 min.
Flasks were placed in a shaking incubator at 28°C and
190 rpm. Samples (0.3 mL) were removed from flasks,
centrifuged for 4 min at 9000 rpm to remove adsorbed
phages, and measurements were performed by direct plat-
ing with the soft agar overlay technique. Adsorption rate
constants of phage onto bacteria were calculated by the
formula: dp/dt = K[P][B], where dP/dt is the rate of
adsorption of phage onto bacteria (phage/mL/min), [P]
and [B] are concentrations of phage and bacteria, respec-
tively, and K is the adsorption constant.
Symbiodinium culture preparation
Symbiodinium growth medium was prepared by combin-
ing a modified F/2 dinoflagellate media and Erdschrei-
ber media (Guillard and Ryther 1962). Seawater was
supplemented with 4 mg/L Na2HPO4, 1 g/L NaNO3,
1 mL/L from a 10009 concentrated A5+CO micronutrient
solution (described by Sussman et al. 2009), 2.5 mg/L
GeO2, 80 mg/L G-penicillin, 80 mg/L streptomycin,
40 mg/L amphotericin, 0.4 mg/L thiamine HCl, 2 lg/L
biotin, and 2 lg/L vitamin B12 (cyanocobalamin). The
growth medium was 0.22 lm filtered and stored at 4°C
in the dark. Before use, the 0.22-lm filtration was
repeated. Symbiodinium cultures grown in F2 medium
were inoculated into sterile 96-well plates (100 lL per
well), covered and sealed. Plates were incubated at 26°C
under 12 h:12 h light:dark irradiance (120 pmol photons/
m2/sec). Cells were inspected daily and contaminated
plates were discarded. Before experimental exposure,
Symbiodinium cells were quantified (n = 10) using a
Neubauer hemocytometer and adjusted to a uniform
concentration (1 9 106 cells/mL) by adding F/2 medium,
and transferred into new sterile 96-well microtiter plates
(100 lL per well). The microtiter plates were incubated
at 26°C under 12 h light:12 h dark photoperiods
(120 pmol photons/m2/sec) and before experimental
exposure temperature was raised to 28°C at a rate of 1°C
per day.
Quantum yield measurements and PSII
inactivation rates
Ten-milliliter cultures of P1 bacteria were grown for 20 h
at 28°C and 190 rpm to reach a concentration of 109
bacteria mL1. A separate culture of strain P1 (10 mL)
was grown for 20 h with 104 phage YC added after 4 h of
bacterial growth. Cultures were centrifuged at 5250g for
10 min and subsequently filtered through 0.22-lm syringe
filters. Hundred microliters of clarified supernatant was
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then added to each microtiter well (each supernatant
treatment was conducted in triplicate) and exposed to a
maxi imaging pulse amplitude modulation (MAXI iPAM)
fluorometer saturation light pulse (Gain = 1–2, Inten-
sity = 1–2, Saturation pulse = 7) at 0, 1, 2, and 4 h
followed by 4-h intervals up to 24 h. The Symbiodinium
cells were dark adapted for 30 min prior to each mea-
surement to obtain dark adapted quantum yields (QYs)
(Fv/Fm), which were calculated using the formula, Fv/
Fm = (Fm  F0)/Fm (Fm = maximum fluorescent yield,
F0 = dark fluorescent yield). PSII inactivation rates were
calculated as proportions from the control wells containing
only Symbiodinium cells only ([QYcontrol  QYtreatment]/
QYcontrol) 9 100).
Effect of different concentrations of strain
P1 with Bacteriophage YC on
photoinactivation rates of coral
endosymbionts
Bacteria were grown in 50-mL Falcon tubes for 20 h at
28°C and 190 rpm in a shaking incubator to reach a con-
centration of 109 cells/mL before being diluted with
FASW to reach concentrations of 105–109 cells/mL
(verified by plating on TCBS [thiosulfate-citrate-bile salts-
sucrose] agar plates). For each concentration, two sepa-
rate tubes were prepared, one with addition of 104 phage/
mL and another with no phage addition. All tubes were
placed in a shaking incubator at 28°C and 190 rpm for
5 h and samples were then centrifuged and filtered
through a 0.22-lm filter to obtain bacteria-free superna-
tants. From each sample, 100 lL of derived supernatant
was added to wells of a 96-well microtiter plate contain-
ing 100 lL of 106 mL1 Symbiodinium cells. The plate
was exposed to a maxi iPAM fluorometer saturation light
pulse (Gain = 1–2, Intensity = 1–2, Saturation pulse = 7)
at 0, 1, 2, and 4 h followed by 4-h time intervals until
36 h. PSII inactivation rates were calculated as propor-
tions from quantum yield measurements by the MAXI
iPAM fluorometer.
Collection and maintenance of Acropora
millepora coral juveniles
Acropora millepora coral juveniles were raised from larvae
as described by Abrego et al. (2008) and Littman et al.
(2010). Briefly, A. millepora parental colonies were col-
lected from Cattle Bay, Orpheus Island, prior to spawning
in November 2010. Following spawning, gametes were
reared at Orpheus Island Research Station to produce lar-
vae. After settlement and infection with clade D algal
symbiont, the coral juveniles were returned to the waters
off of Pelorus Island. Juveniles attached to terra cotta tiles
were placed on steel rods and suspended horizontally
between pairs of metal star-pickets on the reef flat on the
west side of Pelorus Island where they were allowed to
grow for 6 months. The terracotta tile racks were
removed from the reef by snorkeling and carried in large
containers to the Australian Institute of Marine Science
(AIMS) where they were placed in outdoor aquaria facili-
ties with 5 lm filtered flow through seawater for 1 week
to allow acclimatization. After 1 week, juveniles were
removed from the tiles using a microscope, scalpel, and
tweezers and placed into individual wells in a 12-well
plate with 5 mL of FASW. All plates containing juveniles
were incubated at 24°C under 12 h light:12 h dark pho-
toperiods with irradiance of 120 pmol/m2/sec. A health
assessment of the juveniles was performed every 2 days,
checking the pigmentation and juvenile’s extracted tenta-
cles. Juveniles displaying signs of stress were removed
from the plates. In addition, FASW was replaced every
2 days with fresh 5 mL of FASW. After 5 days, the tem-
perature was elevated by 2°C from 24°C to 26°C and
5 days after the temperature was again increased to 28°C.
Phage therapy experiment on A. millepora
coral juveniles
Three individual colonies of strain P1 were inoculated
into separate culture tubes of MBT medium and FASW
at a 1:1 ratio (5 mL MBT: 5 mL FASW) and incubated
for 24 h in a shaking incubator at 190 rpm with phage
YC (104 mL1) added at different time points of bacterial
growth (2, 8, and 18 h). Overnight cultures were centri-
fuged and filtered leaving clear, bacteria-free supernatants.
To each well containing an A. millepora juvenile, FASW
and supernatant at a 1:1 ratio (2 mL FASW: 2 mL of
supernatant) was added. Interval measurements (0, 1, 3,
6, 9, and 12 h) of quantum yield and PSII inactivation
rate were determined using a MAXI iPAM fluorometer,
and the change in the juveniles’ morphology (0, 1, 3, 6,
and 9 h) was observed using a dissecting microscope and
digital camera. Controls consisted of juveniles exposed
only to the addition of FASW.
Results
Phage isolation and characterization
Bacteriophages specific for the coral pathogen V. corallii-
lyticus strain P1 were isolated from filtered and
chloroform-treated seawater. Clear plaques were observed
on P1 bacterial lawns grown on MA agar. A single plaque,
referred to as phage YC, was selected and further purified
for this study. Electron micrograph images of the YC bac-
teriophage were obtained from highly concentrated phage
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lysates (Fig. 1A and B). The phage demonstrated a non-
enveloped, head–tail structure. The tail is contractile and
the capsid has elongated icosahedral symmetry morpho-
logy consistent with the Myoviridae family. The genome
size of the YC phage was determined by total extraction
of DNA and comparison with standards on a 1% agarose
gel, which showed that the phage has a small genome of
11 kb. The phage nucleic acid was sensitive to DNAse but
not RNAse indicating it is a DNA phage. The packaged
viral genomic DNA can be observed in the TEM micro-
graph inside the capsid head that has a 90-nm diameter
(Fig. 1A). The phage tail is 80 nm which is characteristic
of the size of the Myoviridae family of viruses (Fig. 1B).
The latent phase for bacteriophage lysis of the P1 strain
was 60 min as determined by a one-step burst size
experiment (Fig. 2). The experiment was conducted in
nutrient-rich MBT medium to partially mimic the nutri-
ent-rich environment that a bacterium may experience in
the coral mucus. Absorption of the phage to the bacte-
rium is rapid and occurred within 5 min at 30°C. The
burst size was 500 phage particles per infected bacterial
cell. The adsorption rate of bacteriophage YC in low
nutrient medium was determined in an attempt to mimic
the behavior and efficiency of the phage in seawater sam-
ples. For concentrations of 105 P1/mL and 104 phage/mL
in low nutrient media, an adsorption of 70% was observed
after 50 min (Table 1). At concentrations of 104 P1 and 104
phage/mL, adsorption of 45% after 60 min was observed.
For the low bacterial concentration treatment of 103 P1 and
104 phage/mL, adsorption of 41% was observed after
60 min. The average K value for all three treatments was
4.8 9 105  2.6 9 106 phage/mL/min (SE).
Effect of bacteriophage YC on
V. coralliilyticus-induced Symbiodinium
photosynthesis inhibition
Symbiodinium cultures of clade D treated with P1 bacte-
rial supernatant showed a decrease in the photosynthetic
Table 1. Phage YC Adsorption Kinetics onto P1 bacteria.
Concentration of bacteria and phage 105 P1 + 104 phage YC 104 P1 + 104 phage YC 103 P1 + 104 phage YC
Adsorption in time 70% in 50 min 45% in 60 min 41% in 60 min
Adsorption rate (K) Average K value for the experiment = 4.8 9 105  2.61 9 106 phage/mL/min
100 nm
200 nm
Phage 1
Phage 2
(A)
(B)
Figure 1. Transmission electron microscope (TEM) micrographs of
negatively stained bacteriophage YC. (A) A 100-nm scale TEM photo
shows the hexagonal capsid head of phage YC and the contractile tale.
(B) A 200-nm scale TEM photo shows phage YC genomic DNA inside its
capsid. Phage 1 shows the noncontractile tail outline. Phage 2 shows
the contractile tail outline that is 50% shorter than the noncontractile
mode. According to its morphology, phage YC is a member of the
Myoviridae family.
PF
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Figure 2. One-step growth curve and burst size of bacteriophage
YC in MBT medium. Phage YC was used at multiplicity of infection
(M.O.I.) of 0.01.
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activity after the P1 supernatant was added. For example,
after 12 h, the quantum yield of Symbiodinium decreased
by 40%, and by 24 h, a 90% reduction in the Symbiodini-
um quantum yield was observed (Fig. 3). In contrast, the
quantum yield of Symbiodinium exposed to the superna-
tant of P1 bacteria infected with bacteriophage YC
showed no change in their quantum yield values and
resembled the controls (Fig. 3).
The PSII photoinactivation rate of the corals’ Symbiodi-
nium endosymbionts exposed to different concentrations
of V. coralliilyticus strain P1 supernatant was directly
related to the concentration of supernatant added. All
concentrations of bacterial supernatant caused strong
photoinactivation (>90%), though higher concentrations
of P1 supernatant demonstrated higher photoinactivation
rates over the 36-h experiment. For example, supernatant
extracted from 109 P1 cells resulted in a 100% inactiva-
tion rate while supernatant extracted from 105 P1 cells
caused 91.1% of inactivation rate after 36 h (Fig. 4).
When 104 phages were added to each concentration of
P1, photoinactivation rates of the Symbiodinium endo-
symbionts were significantly lower (P < 0.005). For exam-
ple, bacterial supernatants extracted from 109 P1 cells
with added phage caused only 50% photoinactivation of
Symbiodinium cells. Photoinactivation rates were even
lower (only 9.2%) when Symbiodinium cells were exposed
to supernatant from 106 P1 cells with phage addition. In
general, the extent of photoinactivation was lower when
phage was added to more dilute bacterial cultures.
Phage therapy of A. millepora coral
juveniles
Phage therapy of A. millepora coral juveniles, measured
indirectly by inhibition of coral photosynthesis, was per-
formed to examine phage treatment efficiency on live
coral. Addition of V. coralliilyticus P1 supernatant to the
wells of microtiter plates holding individual 6-month-old
coral juveniles resulted in an immediate visible response.
Images derived from a dissecting microscope and digital
camera showed the coral’s polyps immediately retract and
after 1 h Symbiodinium cells were observed to be expelled
from the coral tissue. After 3 h, degradation of the coe-
nosarc tissue (the tissue between the polyps) was
observed. After 6 h, tissue lesions appeared and after 9 h
only skeleton remained (Fig. 5). The iPAM measurements
showed a rapid decline in the coral’s quantum yield and
after 6 h of incubation, low values of 0.041 (compared
with control values of 0.4) were recorded while after 12-h
quantum yield measurements had fallen to zero (Fig. 6A).
Calculations of PSII inactivation rates showed a complete
inactivation of the reaction center after 9 h (Fig. 6B).
Supernatant derived from P1 bacteria with added phage
after 2 h of bacterial growth demonstrated very different
effects on the A. millepora juveniles. Dissecting micro-
scope images showed no change in the appearance of the
corals and no signs of Symbiodinium cells expulsion dur-
ing the entire 12-h experiment. iPAM measurements
showed no decline in coral quantum yields, with a value
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Figure 3. Photosynthetic quantum yield measurements of
Symbiodinium after exposure to Vibrio coralliilyticus P1 bacterial
supernatants with and without bacteriophage YC treatment.
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ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd. 69
Y. Cohen et al. Phage Therapy of Vibrio coralliilyticus
of 0.388 (0.02 SE) recorded at T = 0 and values of
0.398 (0.05 SE) and 0.360 (0.04 SE) recorded after
6 h and 12 h of the experiment, respectively. A low inac-
tivation rate of 7% was observed after 12 h. Assays on
A. millepora juveniles using supernatant derived from P1
bacteria with phage added after 8 h of bacterial growth
showed a similar effect to the control corals treated with
the P1 supernatant without added phage. After 3 h of
supernatant exposure, Symbiodinium cells were observed
to be expelled from the coral tissue, and after 6 h distinct
tissue lesions were observed on the juveniles resulting in
exposed coral skeleton free of live coral tissue. iPAM
measurements showed a slower decline in the quantum
yield rates from 0.350 (0.01 SE) at T = 0 to 0.254
(0.02 SE) after 12 h. PSII reaction centers demonstrated
an inactivation rate of 20% after 9 h. The effect on the
coral juveniles of supernatant derived from P1 grown for
18 h before exposure to the phage was similar to P1
supernatants with no phage addition and P1 supernatant
with phage added 8 h after growth. Tissue lesions were
observed after 6 h and exposed coral skeleton observed
after 9 h of exposure. Although the decline in the quan-
tum yield by this treatment was more moderate than the
decline in the P1 supernatant treatment, iPAM results
showed a decrease in the quantum yield of the treated
juveniles, with a rate of zero recorded after 12 h.
Discussion
Coral disease outbreaks pose a serious risk to reef eco-
systems through the destruction of reef-building corals.
Robust and tangible reef management practices need to
be developed to prevent coral disease outbreaks and pre-
serve reefs currently subjected to increased anthropo-
genic stress and high prevalence of disease. Phage
therapy, which involves the application of a virus (or
viruses) that specifically kill an identified bacterial patho-
gen, represents one potential management tool that can
be applied at reef-wide scales to manage disease out-
breaks. Previous studies have identified and characterized
phages specific to disease pathogens in the Gulf of Eilat
in the Red Sea. This study expanded the research on
phage therapy to a different geographic area, by isolating
and testing the first coral pathogen-specific phage out-
side of the Red Sea, and examined the physiological
response of V. coralliilyticus strain P1, previously identi-
fied as the causative agent of the white syndrome disease
in Montipora auquiberculata corals (Sussman et al.
2008). This study also adapted models for coral health,
including coral endosymbionts (Symbiodinium) and
reared coral juveniles of A. millepora, to observe the
effects of treatment of the coral pathogen with a specific
lytic bacteriophage.
(A) (B)
(C) (D)
Figure 5. Dissecting microscopy photos of Acropora millepora coral juveniles after treatment with: (A) FASW only (i.e. negative control) at
T = 9 h, (B) Vibrio coralliilyticus P1 supernatant at T = 9 h, (C) Supernatant extracted from P1 that grew in the presence of bacteriophage YC
at T = 0 h, and (D) Supernatant extracted from P1 that grew in the presence of bacteriophage YC at T = 9 h.
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In natural environments, phages and their bacterial
hosts maintain equilibrium. Populations of bacteria that
bloom are often controlled by phage infection which sub-
sequently reduces their numbers, the “kill the winner”
theory (Thingstad 2000). Therefore, in natural ecosystems,
wherever bacteria can be isolated, a specific phage can
also generally be found (Chibani-Chennoufi et al. 2004;
Stenholm et al. 2008). In this study, a bacteriophage spe-
cific to the identified coral pathogen V. coralliilyticus
strain P1 was successfully isolated from waters of Nelly
Bay, Magnetic Island. This was the location where the
Vibrio pathogen was first isolated from diseased corals
(Sussman et al. 2008). Phage YC showed high specificity
to its host and was not shown to infect other strains of
V. coralliilyticus, including strains P2 and P3 (Isolated by
Sussman et al. 2008). The natural concentrations of phage
in seawater can fluctuate with the season, UV light expo-
sure, temperature, and bacterial host densities. In addi-
tion, changes in the phage concentrations might be
related to a disease outbreak as it is correlated with a rise
in the concentration of pathogenic bacteria. Phage YC
was isolated in the summer when sea surface tempera-
tures were 28°C and disease prevalence was relatively
high (Haapkyla et al. 2010). A bacteriophage specific for
V. coralliilyticus could only be isolated from sampled sea-
water treated with 0.5% chloroform. Untreated samples
showed no specific enrichment for V. coralliilyticus spe-
cific phages indicating the YC phage may have been
attached to the outside of the bacterium or in a pseudo-
lysogenic state within the natural populations of V. coral-
liilyticus. Chloroform is effective at causing cell disruption
and may have released the phage. This observation is con-
sistent with the concept that phages would “prefer” to
remain associated with the bacterium, as a survival strat-
egy, when the host in the natural environment is at low
densities (Moebus 1996). When phage YC was plated by
the soft agar overlay technique after a second enrichment
on nutrient-rich media, clear viable plaques were estab-
lished on the MA plate. It is possible that some of the
phage turned to the lytic cycle when the environment
became more favorable to its host.
TEM photos of the isolated phage indicated that it
belongs to the Myoviridae family based on its conserved
and highly characteristic morphology. No genotypic char-
acterization was possible as there are no taxonomic
genetic markers for identification of phages (Paul and
Sullivan 2005). If we rank phage YC according to the
rank-abundance curve (Suttle 2005), it appears to be an
r-selected strategist: small, virulent, opportunists, which
replicate quickly, have short life cycles and produce many
progeny.
Several studies have examined marine phage adsorption
kinetics and a comparison between adsorption rates of
these marine phages highlights that phage YC has a high
adsorption rate (Table 2). Furthermore, the phage
absorption kinetics of YC were similar to BA3 bacterio-
phage that was used in a previous study against
white-plague-like coral disease in the Red Sea (Efrony
et al. 2009). The adsorption constant (K) of 4.8 9
105  2.6 9 106 phage/mL/min indicates that YC is
capable of rapidly adsorbing onto V. coralliilyticus P1. No
threshold value was observed for phage absorption at low
bacterial concentrations of 103 cells/mL in contrast to
previous phage kinetic studies (Payne and Jansen 2001).
The phage was also successful in binding to the target
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Figure 6. (A) Maxi imaging pulse amplitude modulation (PAM)
quantum yield measurement of Acropora millepora coral juveniles
after treatment with P1 supernatant and P1 supernatant with phage
adding after 2, 8, and 18 h. Measurements were taken at time points
of 0, 1, 3, 6, 9, and 12 h. Before each measurement, juveniles were
dark adapted for 30 min. (B) Maxi imaging PAM Symbiodinium PSII
inactivation rates after treatment with P1 supernatant and P1
supernatant with phage adding after 2, 8, and 18 h. PSII inactivation
was calculated as a proportion from the quantum yield measurement
of A. millepora coral juveniles.
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V. coralliilyticus P1 strain in seawater with a burst of 500
new phages when it comes into contact with a nutrient-
rich area similar to coral mucus.
Bacterial causative agents for a number of specific coral
diseases have been previously identified (Rosenberg et al.
2007); however, little is known regarding specific bacterial
virulence mechanisms that enable the lesions to progress.
Studies investigating the virulence mechanisms of the
coral pathogen V. coralliilyticus demonstrated that an
expressed Zn metalloprotease caused photoinactivation of
the coral photosynthetic Symbiodinium endosymbionts
(Banin et al. 2003; Ben-Haim et al. 2003a,b; Sussman
et al. 2009). Moreover, a recent study by De Santos et al.
(2011) demonstrated that strain P1 has a diverse reper-
toire of metalloproteases that enable V. coralliilyticus to
be potentially highly virulent. The addition of phage YC
to the growth medium of the P1 strain resulted in lysis of
the bacterium and therefore presumably prevented
expression of the metalloprotease and subsequent inhibi-
tion of the photosystems of the Symbiodinium cells.
Symbiodinium cells in the coral juvenile did not show any
effect of the Zn metalloprotease on its quantum yield,
when supernatant produced from P1 strain with phage
added to culture after 2-h growth was dosed onto the
coral. Sussman et al. (2009) demonstrated that the pro-
duction rate of Zn metalloprotease is highest at bacterial
densities of 108–109 cells/mL and that the bacterium con-
tinues to produce metalloprotease at high rates even after
reaching the stationary growth phase. Addition of the
phage to the bacterial cultures reduced Symbiodinium PSII
inactivation rates rapidly even at high concentrations of
bacteria (109 cells/mL). This phage addition lysed the bac-
terial pathogen and presumably stopped Zn-metallo-
protease production and further damage to Symbiodinium
cells. The concentration of a pathogen in a diseased coral
can reach a concentration of almost 109 cells/mL (Israeli
et al. 2001). Therefore, the isolated phage offers good
potential as a treatment to stop the spread of a pathogen
to other corals. When added at an early stage of disease
progression, the phage has the potential to help the coral
and its associated endosymbionts defend themselves
against pathogen invasion.
Coral juveniles represent an excellent model system to
study coral’s Symbiodinium recruitment, coral fitness,
and coral disease mechanisms (Abrego et al. 2009; Mieog
et al. 2009; Sussman et al. 2009). Sussman et al. (2009)
showed that coral juveniles demonstrate characteristic
disease signs when exposed to bacterial supernatants of
strain P1, Symbiodinium PSII inactivation, paling of
coral tissue as a result of loss in Symbiodinium cells
followed by formation of coral tissue lesions and subse-
quent mortality. The disease signs observed on the juve-
niles are similar to disease signs observed on the coral
reef (Anthony et al. 2008) and during laboratory infec-
tion experiments (Sussman et al. 2008). In the current
study, juvenile exposure experiments were successfully
repeated and extended to examine the potential for bac-
teriophage addition to protect the health of the coral
juveniles. When the phage YC was added to the P1 bac-
terial strain, it was able to prevent the disease signs
within the juveniles.
In conclusion, this study has isolated and identified a
phage effective against the coral pathogen V. coralliilyticus.
The Myoviridae-like phage possesses properties important
for effective action against the bacterial pathogen and
therefore represents an agent that has potential for treat-
ment of localized coral disease outbreaks. Further research
is required, however, to examine the feasibility of such
a treatment in adult corals along with the benefits and
risks of phage therapy treatments in an open coral reef
ecosystems.
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